These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 24896070)

  • 1. The role of teriparatide in sequential and combination therapy of osteoporosis.
    Meier C; Lamy O; Krieg MA; Mellinghoff HU; Felder M; Ferrari S; Rizzoli R
    Swiss Med Wkly; 2014; 144():w13952. PubMed ID: 24896070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF; Hamdy NA; Netelenbos JC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):132-7. PubMed ID: 16463613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic therapy for osteoporosis.
    Bilezikian JP
    Int J Fertil Womens Med; 2005; 50(2):53-60. PubMed ID: 16334411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
    Hodsman AB; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; Kendler DL; McClung MR; Miller PD; Olszynski WP; Orwoll E; Yuen CK
    Endocr Rev; 2005 Aug; 26(5):688-703. PubMed ID: 15769903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of osteoporosis with parathyroid hormone and teriparatide.
    Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K
    Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone as an anabolic skeletal therapy.
    Rubin MR; Bilezikian JP
    Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications to teriparatide treatment in patients with osteoporosis.
    Rizzoli R; Kraenzlin M; Krieg MA; Mellinghoff HU; Lamy O; Lippuner K
    Swiss Med Wkly; 2011; 141():w13297. PubMed ID: 22057669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window.
    Bilezikian JP
    Curr Osteoporos Rep; 2008 Mar; 6(1):24-30. PubMed ID: 18430397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
    Bilezikian JP; Rubin MR
    Curr Osteoporos Rep; 2006 Mar; 4(1):5-13. PubMed ID: 16527002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of teriparatide and its clinical efficacy in the treatment of osteoporosis.
    Dobnig H
    Expert Opin Pharmacother; 2004 May; 5(5):1153-62. PubMed ID: 15155114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with recombinant parathyroid hormone of advanced osteoporosis--series of cases].
    Skiba K; Adamczak M; Wiecek A
    Przegl Lek; 2011; 68(7):391-5. PubMed ID: 22010479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches.
    Langdahl B
    Bone; 2020 Oct; 139():115516. PubMed ID: 32622871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic targets for osteoporosis.
    Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
    Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide.
    Maugeri D; Russo E; Luca S; Leotta C; Mamazza G; Sorace R; Rizzotto M; Manuele S; Fiore V; Taverna G; Castiglia B; Calitro M
    Arch Gerontol Geriatr; 2009; 49(1):35-8. PubMed ID: 18555544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone analogues in the treatment of osteoporosis.
    Kraenzlin ME; Meier C
    Nat Rev Endocrinol; 2011 Jul; 7(11):647-56. PubMed ID: 21750510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
    Ebeling PR; Russell RG
    Int J Clin Pract; 2003 Oct; 57(8):710-8. PubMed ID: 14627183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
    Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.